Evaluation of skeletal muscle mass in patients with chronic liver disease shows different results based on bioelectric impedance analysis and computed tomography

Annals of Nutrition and Metabolism

Clinical Study: Research Article

Open Access Gateway Kikuchi N. · Uojima H. · Hidaka H. · Iwasaki S. · Wada N. · Kubota K. · Nakazawa T. · Shibuya A. · Kako M. · Také A. · Sakaguchi Y. · Sato T. · Kusano C.
Abstract

Aim: We aimed to evaluate the difference between computed tomography (CT) and bioelectrical impedance analysis (BIA) -based assessment of sarcopenia in patients with chronic liver disease (CLD). Methods: We enrolled a total of 257 patients who was diagnosed with sarcopenia by CT and BIA based on the Japan Society of Hepatology. To evaluate whether or not the different methods influence the diagnosis of sarcopenia for the patients with CLD, we assessed the number and characteristics of mismatch between the low SMI using BIA and CT. We also compared with the overall survival (OS) in patients with sarcopenia and non-sarcopenia base on CT and BIA to evaluate the appropriate methods. Results: The number of patients with low SMI using BIA and CT was 28 (10.9%) and 68 (26.5%) patients, respectively. Multivariate analysis revealed that hepatic ascites and body weight were independent factors of mismatch between SMI using BIA and CT (hazard ratio [HR] 3.232, P

The Author(s). Published by S. Karger AG, Basel

Article / Publication Details Open Access License / Drug Dosage / Disclaimer This article is licensed under the Creative Commons Attribution 4.0 International License (CC BY). Usage, derivative works and distribution are permitted provided that proper credit is given to the author and the original publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

留言 (0)

沒有登入
gif